Director John Squires delivered his first public remarks on Friday, addressing a number of key issues he has been focused on during his first five weeks in office.

Patent pruning is undergoing a transformation. What was once viewed as a routine cost management task is now becoming a ...

The U.S. Food and Drug Administration (FDA) announced on Wednesday that it will be making it easier to develop biosimilar drugs in its ongoing effort to lower drug prices.

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision on Thursday, in part clarifying its ...

Today’s AI technology has unlocked the possibility of universal access to professional-grade patent intelligence.

Yesterday, USPTO Director John Squires sent a memo to all PTAB administrative patent judges informing them that the agency ...

The Trump Administration this week asked the Chief Justice of the U.S. Supreme Court to stay an interlocutory injunction that ...

On October 24, the Patent Office Professional Association (POPA) and another union filed a motion for a preliminary ...

U.S. Patent and Trademark Office (USPTO) Director John Squires delivered his first public remarks on Friday, addressing a number of key issues he has been focused on during his first five weeks in ...